Your browser doesn't support javascript.
Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants.
Chi, Xiangyang; Xia, Lingyun; Zhang, Guanying; Chi, Ximin; Huang, Bangdong; Zhang, Yuanyuan; Chen, Zhengshan; Han, Jin; Wu, Liushu; Li, Zeya; Sun, Hancong; Huang, Ping; Yu, Changming; Chen, Wei; Zhou, Qiang.
  • Chi X; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China.
  • Xia L; Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, Institute of Biology, Westlake Institute for Advanced Study, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.
  • Zhang G; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China.
  • Chi X; Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, Institute of Biology, Westlake Institute for Advanced Study, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.
  • Huang B; Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, Institute of Biology, Westlake Institute for Advanced Study, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.
  • Zhang Y; Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, Institute of Biology, Westlake Institute for Advanced Study, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.
  • Chen Z; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China.
  • Han J; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China.
  • Wu L; Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, Institute of Biology, Westlake Institute for Advanced Study, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.
  • Li Z; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China.
  • Sun H; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China.
  • Huang P; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China.
  • Yu C; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China. yuchangming@126.com.
  • Chen W; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China. cw0226@foxmail.com.
  • Zhou Q; Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, Institute of Biology, Westlake Institute for Advanced Study, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China. zhouqiang@wes
Cell Discov ; 9(1): 37, 2023 Apr 04.
Article in English | MEDLINE | ID: covidwho-2254818
ABSTRACT
The pandemic of COVID-19 caused by SARS-CoV-2 continues to spread around the world. Mutant strains of SARS-CoV-2 are constantly emerging. At present, Omicron variants have become mainstream. In this work, we carried out a systematic and comprehensive analysis of the reported spike protein antibodies, counting the epitopes and genotypes of these antibodies. We further comprehensively analyzed the impact of Omicron mutations on antibody epitopes and classified these antibodies according to their binding patterns. We found that the epitopes of the H-RBD class antibodies were significantly less affected by Omicron mutations than other classes. Binding and virus neutralization experiments showed that such antibodies could effectively inhibit the immune escape of Omicron. Cryo-EM results showed that this class of antibodies utilized a conserved mechanism to neutralize SARS-CoV-2. Our results greatly help us deeply understand the impact of Omicron mutations. Meanwhile, it also provides guidance and insights for developing Omicron antibodies and vaccines.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Systematic review/Meta Analysis Topics: Vaccines / Variants Language: English Journal: Cell Discov Year: 2023 Document Type: Article Affiliation country: S41421-023-00535-1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Systematic review/Meta Analysis Topics: Vaccines / Variants Language: English Journal: Cell Discov Year: 2023 Document Type: Article Affiliation country: S41421-023-00535-1